How effective is venetoclax in the treatment of acute myeloid leukemia in adults?

Venetoclax is a type of lymphoma called B cell lymphoma-2 (< /span>BCL-2) inhibitor drugs, which work by blocking the action of a certain protein in the body that helps cancer cells survive, which helps kill cancer cells. Veneclat used alone or in combination with obinutuzumab (Gazyva) or rituximab (Rituxan) Used together to treat certain types of chronic lymphocytic leukemia (CLL) or certain types of small lymphocytic lymphoma (SLL). Venecla is also used in combination with azacitidine (Vidaza), decitabine (Dacogen) or cytarabine as an acute myeloid leukemia leukemia (AMLa cancer that starts in white blood cells), for people 75 and over years of age, or adults with diseases that cannot be treated with other chemotherapy drugs.

How effective is venetoclax in treating acute myeloid leukemia in adults?

Two trials investigated the efficacy of venetoclax in patients 75 and older who were unable to receive intensive induction chemotherapy for one of the following reasons: AML patients. One trial compared the efficacy of venetoclax plus azacitidine (V+A) with venetoclax plus decitabine (V + d). 37%of people in the V+A group experienced a complete response compared to 54% in the V+D group. For patients who achieved CR, the median observed time to response was 5.5 months (range: 0.4 to 30 months). When venetoclax was given in combination with low-dose cytarabine, clinical remission occurred in 21% of patients. The median observed response time was6.0months (range: 0.03 to 25months). The retail price of generic venetoclax100mg120 tablets is from 2 to more than 6 more than 1,000. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.